InVision Medical Technology

InVision Medical Technology leverages artificial intelligence to enhance the accuracy and efficiency of ultrasound interpretation, aiding in the detection of heart diseases that might be overlooked by human analysis. Our sophisticated AI models are seamlessly integrated into existing clinical workflows, ensuring ease of use for medical professionals. The efficacy of our technology is supported by peer-reviewed publications in leading medical journals, including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), and JAMA Cardiology (2022). Furthermore, the results of our randomized, blinded clinical trial evaluating cardiac function were recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology, underscoring the potential of our AI-driven diagnostic tools.